OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Senator Baldwin Demands Big Pharma Stop Unfair Practices that Reduce Competition, Raise Prices for Inhalers

Letter

Date: Jan. 29, 2024
Location: Washington, D.C.
Issues: Health Insurance Health and Health Care

BREAK IN TRANSCRIPT

"Innovative products deserve protection but, for too long, large corporations have bent the rules to unfairly protect themselves from competition and Wisconsinites have paid the price. While drug companies are required to list certain patents in the Orange Book, bad actors can exploit this process to inappropriately deter competition and generic drug development, leading to fewer treatment options and higher prices for consumers.

BREAK IN TRANSCRIPT

The price of anticompetitive behavior is ultimately paid by Wisconsinites, through higher costs, fewer treatments, and worse health. It must stop."

BREAK IN TRANSCRIPT


Source
arrow_upward